Spots Global Cancer Trial Database for Adjuvant vs Surgery Only in Early-stage Recurrent NPC
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Adjuvant vs Surgery Only in Early-stage Recurrent NPC
Official Title: Adjuvant Therapy Versus Endoscopic Surgery Alone in Early-stage Recurrent Nasopharyngeal Carcinoma: A Multicenter Randomized Controlled Trial
Study ID: NCT06228079
Conditions
Study Description
Brief Summary: Adjuvant Therapy Versus Endoscopic Surgery Alone in Early-stage Recurrent Nasopharyngeal Carcinoma: A Multicenter Randomized Controlled Trial
Detailed Description: This study is an open-label, multicentered, evaluator-blinded , randomized clinical trial. Patients with early-stage recurrent nasopharyngeal carcinoma were randomized into the control group and the experimental group. Patients in the control group would go through observation and follow-up after recurrent endoscopic surgery, while patients in the experimental group would be treated with adjuvant therapy such as chemotherapy and immunotherapy. A total of 176 subjects are required, with 88 patients in the control group and 88 patients in the experimental group.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Eye& ENT Hospital, Fudan University, Shanghai, Shanghai, China
Fujian Medical University Union Hospital, Fuzhou, , China
The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, , China
Changhai Hospital, Shanghai, , China
Shanghai Sixth People's Hospital, Shanghai, , China
Shanghai Zhongshan Hospital, Shanghai, , China
Shenzhen Second People's Hospital, Shenzhen, , China
Contact Details
Name: Hongmeng Yu
Affiliation: Eye& ENT Hospital, Fudan University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
